| Significance of HbA1c test in diagnosis and prognosis of diabetic patients SI Sherwani, HA Khan, A Ekhzaimy, A Masood, MK Sakharkar Biomarker insights 11, BMI. S38440, 2016 | 1568 | 2016 |
| Distributions of exons and introns in the human genome MK Sakharkar, VTK Chow, P Kangueane In silico biology 4 (4), 387-393, 2004 | 479 | 2004 |
| Biodegradation of Low Density Polythene (LDPE) by Pseudomonas Species BM Kyaw, R Champakalakshmi, MK Sakharkar, CS Lim, KR Sakharkar Indian journal of microbiology 52, 411-419, 2012 | 398 | 2012 |
| Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro P Jayaraman, MK Sakharkar, CS Lim, TH Tang, KR Sakharkar International journal of biological sciences 6 (6), 556, 2010 | 302 | 2010 |
| Sleep deprivation and neurological disorders M Bishir, A Bhat, MM Essa, O Ekpo, AO Ihunwo, VP Veeraraghavan, ... BioMed research international 2020 (1), 5764017, 2020 | 281 | 2020 |
| Dendritic spines: Revisiting the physiological role SB Chidambaram, AG Rathipriya, SR Bolla, A Bhat, B Ray, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, 161-193, 2019 | 259 | 2019 |
| A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa KR Sakharkar, MK Sakharkar, VTK Chow In silico biology 4 (3), 355-360, 2004 | 230 | 2004 |
| Benefits of curcumin in brain disorders A Bhat, AM Mahalakshmi, B Ray, S Tuladhar, TA Hediyal, E Manthiannem, ... BioFactors 45 (5), 666-689, 2019 | 211 | 2019 |
| Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa S Tin, KR Sakharkar, CS Lim, MK Sakharkar International Journal of Biological Sciences 5 (2), 153, 2009 | 130 | 2009 |
| Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle SB Chidambaram, MM Essa, AG Rathipriya, M Bishir, B Ray, ... Pharmacology & Therapeutics 231, 107988, 2022 | 114 | 2022 |
| Does COVID‐19 contribute to development of neurological disease? AM Mahalakshmi, B Ray, S Tuladhar, A Bhat, S Paneyala, D Patteswari, ... Immunity, inflammation and disease 9 (1), 48-58, 2021 | 94 | 2021 |
| Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders A Bhat, B Ray, AM Mahalakshmi, S Tuladhar, DN Nandakumar, ... Pharmacological research 160, 105078, 2020 | 84 | 2020 |
| An analysis on gene architecture in human and mouse genomes MK Sakharkar, BS Perumal, KR Sakharkar, P Kangueane In silico biology 5 (4), 347-365, 2005 | 81 | 2005 |
| Protein subunit interfaces: heterodimers versus homodimers C Zhanhua, JGK Gan, MK Sakharkar, P Kangueane Bioinformation 1 (2), 28, 2005 | 80 | 2005 |
| Nanoparticles for biomedical applications: An overview HA Khan, MK Sakharkar, A Nayak, U Kishore, A Khan Nanobiomaterials, 357-384, 2018 | 79 | 2018 |
| Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification D Perumal, CS Lim, KR Sakharkar, MK Sakharkar In silico biology 7 (4-5), 453-465, 2007 | 75 | 2007 |
| Naringenin decreases α-synuclein expression and neuroinflammation in MPTP-induced Parkinson’s disease model in mice S Mani, S Sekar, R Barathidasan, T Manivasagam, AJ Thenmozhi, ... Neurotoxicity Research 33, 656-670, 2018 | 73 | 2018 |
| Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer S Thangavel, T Yoshitomi, MK Sakharkar, Y Nagasaki Journal of Controlled Release 209, 110-119, 2015 | 72 | 2015 |
| ExInt: an exon intron database M Sakharkar, F Passetti, JE de Souza, M Long, SJ de Souza Nucleic acids research 30 (1), 191-194, 2002 | 70 | 2002 |
| Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology B Shashni, KR Sakharkar, Y Nagasaki, MK Sakharkar Journal of drug targeting 21 (2), 161-174, 2013 | 66 | 2013 |
